Loading...
PhD Tina Vida Plavec

PhD Tina Vida Plavec
no.: 51651 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
4.06.00  Biotechnical sciences  Biotechnology   
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
365.3
A''
0
A'
148.13
A1/2
291.21
CI10
168
CImax
76
h10
5
A1
1.26
A3
0
Data for the last 5 years (citations for the last 10 years) on September 19, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 11  177  141  12.82 
Scopus 11  203  167  15.18 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (50%, RD:50%)  Jožef Stefan Institute  Odsek za biotehnologijo (Slovene) 
Full time employment (70%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J7-4418  Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections   2022 - 2024  PhD Špela Zupančič  5,566 
2. J7-4420  Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles   2022 - 2024  PhD Aleš Berlec  3,899 
3. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   2021 - 2024  PhD Stane Pajk  2,509 
4. J4-3088  Intra-biofilm dynamics of Campylobacter with other bacteria: effects on biofilm formation and composition with a view to the design of innovative control strategies   2021 - 2024  PhD Anja Klančnik  4,171 
5. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile   2021 - 2024  PhD Borut Štrukelj  3,108 
6. N3-0184  Small protein blockers of IL-23/IL-17 axis as intestinal inflammation inhibitors secreted by probiotic bacteria   2021 - 2024  PhD Aleš Berlec  1,373 
7. J3-50099  A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking   2023 - 2024  PhD Peter Korošec  1,447 
8. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   2022 - 2023  PhD Žiga Jakopin  2,286 
9. J4-1771  NEW ANTIMICROBIAL STRATEGIES IN PREVENTION OF BIOFILM FORMATION BY USING LECTINS THAT INHIBIT BACTERIAL ADHESION   2019 - 2022  PhD Jerica Sabotič  2,087 
10. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   2018 - 2020  PhD Janko Kos  4,640 
11. J3-8201  Nuclear transport defects in neurodegenerative diseases   2018 - 2020  PhD Boris Rogelj  2,344 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P4-0127  Pharmaceutical biotechnology: Science for health   2019 - 2024  PhD Janko Kos  5,158 
2. P4-0127  Pharmaceutical biotechnology: Science for Health   2018  PhD Janko Kos  5,035 
We were not given permission by the researcher to publish data.
Views history
Favourite